Stock Market & Financial Investment News

News Breaks March 5, 2013 16:03 EDT INFI Infinity Pharmaceuticals reports Q4 EPS ($1.15) , consensus (87c) News For INFI From The Last 14 Days Check below for free stories on INFI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 11:20 EDT INFI Infinity Pharmaceuticals shares up 11%, or $1.97, to $19.14 Subscribe for More Information June 11, 2013 06:08 EDT INFI Stocks with implied volatility below IV index mean; MBI INFI Stocks with implied volatility below IV index mean; MBIA (MBI), Infinity Pharmaceuticals (INFI) according to IVolatility. June 10, 2013 11:40 EDT INFI Options with decreasing implied volatility: TIVO INFI NBG UNXL FRAN 07:40 EDT INFI Leerink's biotech analyst holds analyst/industry conference call on ASCO Subscribe for More Information 07:19 EDT INFI Infinity Pharmaceuticals weakness an overreaction, says Stifel After meeting with Infinity's management, Stifel views weakness in the shares following ASCO data as an overreaction. The firm thinks that the ASCO data reaffirmed that IPI-145 is an active drug in iNHL and CLL, and it views the drug as competitive with other hematological malignancy drugs that are being developed. The firm keeps a Buy rating on the stock. 06:38 EDT INFI Stocks with implied volatility below IV index mean; MBI INFI Stocks with implied volatility below IV index mean; MBIA (MBI), Infinity Pharmaceuticals (INFI) according to IVolatility. June 7, 2013 11:56 EDT INFI Options with decreasing implied volatility: TIVO INFI NBG UNXL Subscribe for More Information 06:00 EDT INFI Stocks with implied volatility below IV index mean; CSCO INFI Subscribe for More Information June 6, 2013 12:04 EDT INFI Options with decreasing implied volatility: INFI FRAN GES ANN OVTI 06:16 EDT INFI Stocks with implied volatility below IV index mean; NBG INFY Subscribe for More Information June 5, 2013 13:29 EDT INFI Options with decreasing implied volatility: INFI SRPT GES SUPN CPRT Subscribe for More Information 06:08 EDT INFI Stocks with implied volatility below IV index mean; WCRX INFY Subscribe for More Information June 4, 2013 10:20 EDT INFI Infinity Pharmaceuticals gaps open, spikes higher, levels to watch Subscribe for More Information 09:04 EDT INFI Infinity Pharmaceuticals price target lowered to $32 from $45 at Credit Suisse Subscribe for More Information 07:40 EDT INFI Infinity Pharmaceuticals sell-off appears excessive, says Wells Fargo Subscribe for More Information 07:23 EDT INFI Infinity Pharmaceuticals shares 'too cheap to ignore,' says Piper Jaffray Piper Jaffray recommends buying Infinity Pharmaceuticals shares after the company's ASCO oral presentation of IPI-145 Phase I data in lymphoma patients. Piper says shares are "too cheap to ignore" and keeps an Overweight rating on the name with a $50 price target. Sign up for a free trial to see the rest of the stories you've been missing.